Masanobu Sugawara, Ph.D.
Masanobu joined AnaSpec as Vice President of Operations in 2011 and became President in August, 2014. Prior to joining AnaSpec, he served as Integration Officer at the parent company, Eurogentec S.A. after the company became a member of Kaneka Corporation, a Japanese Chemical Industry in 2010. From 1999 to 2010 he worked at Kaneka (Osaka, Japan) where he was engaged in R&D process chemistry and new business development for pharmaceutical intermediates. He was also responsible for strategic planning including M&A. Masanobu received his PhD in the field of synthetic organic chemistry, organometallics, electro-organic chemistry at Kyoto University, Japan.
Philippe Cronet, Ph.D.
Director, Eurogentec, S.A. Business Unit Research Reagents
Philippe joined AnaSpec in 2011. He brings 15 years of experience in the Pharmaceutical and Life Science Industry together with a broad scientific background. He joined the parent company Eurogentec in 2005 as the Director of the Biologics Contract Manufacturing Unit. In 2008, he took the position of Chief Scientific Officer, heading the Research and Development activities of the company. Prior to Eurogentec, he worked at AstraZeneca where he was heading a team supplying target proteins in the drug discovery process. Philippe carried out his PhD in the field of protein engineering and bioinformatics at the EMBL-Heidelberg.